vs

Side-by-side financial comparison of KINGSTONE COMPANIES, INC. (KINS) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

KINGSTONE COMPANIES, INC. is the larger business by last-quarter revenue ($56.4M vs $44.6M, roughly 1.3× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). KINGSTONE COMPANIES, INC. runs the higher net margin — 26.2% vs -90.4%, a 116.6% gap on every dollar of revenue. On growth, KINGSTONE COMPANIES, INC. posted the faster year-over-year revenue change (34.0% vs 13.8%). KINGSTONE COMPANIES, INC. produced more free cash flow last quarter ($73.1M vs $-19.9M). Over the past eight quarters, KINGSTONE COMPANIES, INC.'s revenue compounded faster (25.6% CAGR vs 7.3%).

Kingstone Companies, Inc., headquartered in Kingston, New York, provides property and casualty insurance products through its subsidiary, Kingstone Insurance Company. It places contracts with the third-party licensed premium finance company through its subsidiary Payments, Inc., a NYS licensed Insurance Premium Finance Company. Kingstone Insurance Company was ranked #1 of the 81 insurers rated by the Professional Insurance Agents Association in its 2010 Company Performance Survey. The company...

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

KINS vs PACB — Head-to-Head

Bigger by revenue
KINS
KINS
1.3× larger
KINS
$56.4M
$44.6M
PACB
Growing faster (revenue YoY)
KINS
KINS
+20.2% gap
KINS
34.0%
13.8%
PACB
Higher net margin
KINS
KINS
116.6% more per $
KINS
26.2%
-90.4%
PACB
More free cash flow
KINS
KINS
$93.0M more FCF
KINS
$73.1M
$-19.9M
PACB
Faster 2-yr revenue CAGR
KINS
KINS
Annualised
KINS
25.6%
7.3%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KINS
KINS
PACB
PACB
Revenue
$56.4M
$44.6M
Net Profit
$14.8M
$-40.4M
Gross Margin
37.1%
Operating Margin
32.7%
-92.3%
Net Margin
26.2%
-90.4%
Revenue YoY
34.0%
13.8%
Net Profit YoY
171.4%
-1802.7%
EPS (diluted)
$1.09
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KINS
KINS
PACB
PACB
Q4 25
$56.4M
$44.6M
Q3 25
$55.7M
$38.4M
Q2 25
$52.3M
$39.8M
Q1 25
$50.5M
$37.2M
Q4 24
$42.1M
$39.2M
Q3 24
$40.8M
$40.0M
Q2 24
$36.5M
$36.0M
Q1 24
$35.8M
$38.8M
Net Profit
KINS
KINS
PACB
PACB
Q4 25
$14.8M
$-40.4M
Q3 25
$10.9M
$-38.0M
Q2 25
$11.3M
$-41.9M
Q1 25
$3.9M
$-426.1M
Q4 24
$5.4M
$2.4M
Q3 24
$7.0M
$-60.7M
Q2 24
$4.5M
$-173.3M
Q1 24
$1.4M
$-78.2M
Gross Margin
KINS
KINS
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
KINS
KINS
PACB
PACB
Q4 25
32.7%
-92.3%
Q3 25
24.6%
-101.1%
Q2 25
27.1%
-112.8%
Q1 25
9.3%
-1154.5%
Q4 24
15.9%
-390.1%
Q3 24
22.3%
-160.3%
Q2 24
15.7%
-488.3%
Q1 24
5.0%
-209.6%
Net Margin
KINS
KINS
PACB
PACB
Q4 25
26.2%
-90.4%
Q3 25
19.5%
-98.9%
Q2 25
21.5%
-105.4%
Q1 25
7.7%
-1146.8%
Q4 24
12.9%
6.0%
Q3 24
17.1%
-151.9%
Q2 24
12.4%
-481.3%
Q1 24
4.0%
-201.4%
EPS (diluted)
KINS
KINS
PACB
PACB
Q4 25
$1.09
$-0.11
Q3 25
$0.74
$-0.13
Q2 25
$0.78
$-0.14
Q1 25
$0.27
$-1.44
Q4 24
$0.44
$-0.44
Q3 24
$0.55
$-0.22
Q2 24
$0.37
$-0.64
Q1 24
$0.12
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KINS
KINS
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$279.5M
Total DebtLower is stronger
$4.4M
Stockholders' EquityBook value
$122.7M
$5.3M
Total Assets
$453.4M
$784.1M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KINS
KINS
PACB
PACB
Q4 25
$279.5M
Q3 25
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
Q4 24
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Total Debt
KINS
KINS
PACB
PACB
Q4 25
$4.4M
Q3 25
$4.8M
Q2 25
$5.1M
Q1 25
$5.4M
Q4 24
$11.2M
Q3 24
$17.3M
Q2 24
$25.3M
Q1 24
$25.3M
Stockholders' Equity
KINS
KINS
PACB
PACB
Q4 25
$122.7M
$5.3M
Q3 25
$107.7M
$36.1M
Q2 25
$94.9M
$61.5M
Q1 25
$82.2M
$91.6M
Q4 24
$66.7M
$506.6M
Q3 24
$59.7M
$453.1M
Q2 24
$40.8M
$492.7M
Q1 24
$35.7M
$649.0M
Total Assets
KINS
KINS
PACB
PACB
Q4 25
$453.4M
$784.1M
Q3 25
$428.6M
$803.2M
Q2 25
$393.4M
$825.5M
Q1 25
$385.4M
$860.8M
Q4 24
$374.9M
$1.3B
Q3 24
$347.0M
$1.5B
Q2 24
$319.8M
$1.5B
Q1 24
$318.3M
$1.7B
Debt / Equity
KINS
KINS
PACB
PACB
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.05×
Q1 25
0.07×
Q4 24
0.17×
Q3 24
0.29×
Q2 24
0.62×
Q1 24
0.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KINS
KINS
PACB
PACB
Operating Cash FlowLast quarter
$75.9M
$-19.1M
Free Cash FlowOCF − Capex
$73.1M
$-19.9M
FCF MarginFCF / Revenue
129.5%
-44.6%
Capex IntensityCapex / Revenue
5.0%
1.9%
Cash ConversionOCF / Net Profit
5.14×
TTM Free Cash FlowTrailing 4 quarters
$124.0M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KINS
KINS
PACB
PACB
Q4 25
$75.9M
$-19.1M
Q3 25
$25.9M
$-18.7M
Q2 25
$9.3M
$-29.4M
Q1 25
$17.9M
$-44.1M
Q4 24
$57.9M
$-30.6M
Q3 24
$21.7M
$-45.5M
Q2 24
$7.1M
$-54.3M
Q1 24
$6.1M
$-75.7M
Free Cash Flow
KINS
KINS
PACB
PACB
Q4 25
$73.1M
$-19.9M
Q3 25
$25.3M
$-18.8M
Q2 25
$8.7M
$-29.9M
Q1 25
$17.0M
$-45.4M
Q4 24
$55.6M
$-32.3M
Q3 24
$21.0M
$-46.3M
Q2 24
$6.6M
$-55.7M
Q1 24
$5.6M
$-79.6M
FCF Margin
KINS
KINS
PACB
PACB
Q4 25
129.5%
-44.6%
Q3 25
45.4%
-48.9%
Q2 25
16.6%
-75.3%
Q1 25
33.7%
-122.3%
Q4 24
132.1%
-82.3%
Q3 24
51.6%
-115.7%
Q2 24
18.1%
-154.8%
Q1 24
15.5%
-205.0%
Capex Intensity
KINS
KINS
PACB
PACB
Q4 25
5.0%
1.9%
Q3 25
1.2%
0.2%
Q2 25
1.1%
1.4%
Q1 25
1.7%
3.7%
Q4 24
5.6%
4.1%
Q3 24
1.7%
2.0%
Q2 24
1.4%
4.1%
Q1 24
1.5%
10.0%
Cash Conversion
KINS
KINS
PACB
PACB
Q4 25
5.14×
Q3 25
2.38×
Q2 25
0.82×
Q1 25
4.60×
Q4 24
10.65×
-12.93×
Q3 24
3.12×
Q2 24
1.58×
Q1 24
4.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KINS
KINS

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons